254 related articles for article (PubMed ID: 9676742)
1. Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex.
Zhang X; Gong ZH; Fasth KJ; Långström B; Nordberg A
Neurochem Int; 1998; 32(5-6):435-41. PubMed ID: 9676742
[TBL] [Abstract][Full Text] [Related]
2. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
3. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.
Sihver W; Gillberg PG; Nordberg A
Neuroscience; 1998 Aug; 85(4):1121-33. PubMed ID: 9681951
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration.
Flores CM; Dávila-García MI; Ulrich YM; Kellar KJ
J Neurochem; 1997 Nov; 69(5):2216-9. PubMed ID: 9349569
[TBL] [Abstract][Full Text] [Related]
5. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.
Warpman U; Nordberg A
Neuroreport; 1995 Nov; 6(17):2419-23. PubMed ID: 8747166
[TBL] [Abstract][Full Text] [Related]
6. Chronic ethanol treatment decreases [3H]epibatidine and [3H]nicotine binding and differentially regulates mRNA levels of nicotinic acetylcholine receptor subunits expressed in M10 and SH-SY5Y neuroblastoma cells.
Gorbounova O; Svensson AL; Jönsson P; Mousavi M; Miao H; Hellström-Lindahl E; Nordberg A
J Neurochem; 1998 Mar; 70(3):1134-42. PubMed ID: 9489734
[TBL] [Abstract][Full Text] [Related]
7. The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells.
Xiao Y; Kellar KJ
J Pharmacol Exp Ther; 2004 Jul; 310(1):98-107. PubMed ID: 15016836
[TBL] [Abstract][Full Text] [Related]
8. Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells.
Warpman U; Friberg L; Gillespie A; Hellström-Lindahl E; Zhang X; Nordberg A
J Neurochem; 1998 May; 70(5):2028-37. PubMed ID: 9572289
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
10. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
[TBL] [Abstract][Full Text] [Related]
11. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
Xiao Y; Meyer EL; Thompson JM; Surin A; Wroblewski J; Kellar KJ
Mol Pharmacol; 1998 Aug; 54(2):322-33. PubMed ID: 9687574
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of 11C-labeled (S)-nicotine, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (R,S)-1-methyl-2-(3-pyridyl)azetidine as nicotinic receptor ligands for positron emission tomography studies.
Sihver W; Fasth KJ; Ogren M; Bivehed H; Bergström M; Nordberg A; Watanabe Y; Långström B
J Neurochem; 1998 Oct; 71(4):1750-60. PubMed ID: 9751211
[TBL] [Abstract][Full Text] [Related]
13. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
[TBL] [Abstract][Full Text] [Related]
14. (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
Sullivan JP; Decker MW; Brioni JD; Donnelly-Roberts D; Anderson DJ; Bannon AW; Kang CH; Adams P; Piattoni-Kaplan M; Buckley MJ
J Pharmacol Exp Ther; 1994 Nov; 271(2):624-31. PubMed ID: 7965777
[TBL] [Abstract][Full Text] [Related]
15. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.
Gopalakrishnan M; Molinari EJ; Sullivan JP
Mol Pharmacol; 1997 Sep; 52(3):524-34. PubMed ID: 9281615
[TBL] [Abstract][Full Text] [Related]
16. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
Parker MJ; Beck A; Luetje CW
Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
[TBL] [Abstract][Full Text] [Related]
17. Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.
Abreo MA; Lin NH; Garvey DS; Gunn DE; Hettinger AM; Wasicak JT; Pavlik PA; Martin YC; Donnelly-roberts DL; Anderson DJ; Sullivan JP; Williams M; Arneric SP; Holladay MW
J Med Chem; 1996 Feb; 39(4):817-25. PubMed ID: 8632405
[TBL] [Abstract][Full Text] [Related]
18. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
Khan IM; Yaksh TL; Taylor P
J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic receptor binding sites in rat primary neuronal cells in culture: characterization and their regulation by chronic nicotine.
Dávila-García MI; Houghtling RA; Qasba SS; Kellar KJ
Brain Res Mol Brain Res; 1999 Mar; 66(1-2):14-23. PubMed ID: 10095073
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of nicotinic receptor-mediated neurotransmitter release following chronic (-)-nicotine administration.
Jacobs I; Anderson DJ; Surowy CS; Puttfarcken PS
Neuropharmacology; 2002 Oct; 43(5):847-56. PubMed ID: 12384170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
